Bavarian Nordic A/S revenue for the last year amounted to 1.05 B USD, the most of which — 1.05 B USD — came from its highest performing source at the moment, Life-Saving Vaccines, the year earlier bringing 452.14 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Bavarian Nordic A/S 381.47 M USD, and the year before that — 120.76 M USD.